SRTA
Strata Critical Medical, Inc. Class A Common Stock
AIR TRANSPORTATION, NONSCHEDULED
Strata Critical Medical (SRTA) Stock: Buy, Sell, or Hold?
$5.77
-0.24 (-3.99%)
▼
5d:
+9.7%
30d:
+34.81%
90d:
-2.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (13%)
Quality Score
31/100
Position
EXTENDED
30-Day Fair Range
$4.33 – $5.22
Position: EXTENDED
Forward P/E & Valuation
74.5x
STRETCHED
vs 62.9x historical avg
Wall Street Target
$9.63
+66.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.21 / $6.20
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: SRTA is 10.5% above its trading range ($5.22). Market expects 5.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $5.77, which is considered extended relative to its 30-day fair value range of $4.33 to $5.22. From a valuation perspective, the stock is trading at a premium (Forward PE: 74.5) compared to its historical average (62.9). At these levels, the market is pricing in 5.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTA is in a downtrend. Immediate support is located at $4.21, while resistance sits at $6.20. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: SRTA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.62 (+66.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTA is in a downtrend. Immediate support is located at $4.21, while resistance sits at $6.20. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: SRTA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.62 (+66.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.33 -
$5.22
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
13.3%
Trading Range & Key Levels
30-Day Trading Range
$4.33 -
$5.22
Current vs Trading Range
EXTENDED
Support Level
$4.21
Resistance Level
$6.20
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+10.5% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 66.8% below Wall St target ($9.62)
- NEUTRAL: Trading at premium valuation - market expects 5.8% growth which is achievable
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
74.45
Wall Street Target
$9.63
(+66.8%)
Revenue Growth (YoY)
50.3%
Profit Margin
-8.8%
Valuation Premium vs History
+5.8% premium
PE vs Historical
74.5 vs 62.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.8%
(market-implied from PE analysis)
1-Year Target
$6.10
(+6%)
2-Year Target
$6.46
(+12%)
3-Year Target
$6.83
(+18%)
3-Yr Target (if PE normalizes)
(PE: 74→63)
PE COMPRESSION
$5.77
(+0%)
Earnings growth offset by PE compression
Share SRTA Analysis
Share this live SRTA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SRTA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about $SRTA's potential to surge above $7, indicating a positive outlook.
Key Retail Themes:
Price level optimism
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:26 PM ET
Data refreshes hourly during market hours. Next update: 5:26 PM
Data refreshes hourly during market hours. Next update: 5:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 39 SELL |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 31 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 45 HOLD |
|
PNTG
Pennant Group Inc |
STRONG BUY
7 analysts |
$48 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SRTA Research Pages